In addition, the reduced P/T ratio of IGlar U100, when comparedto NPH, lowered the risk of nocturnal hypoglycemia, providing a tangible benefit andclinical advance in basal insulin replacement (1). The gene discussed is INS; the disease is Hypoglycemia.